| Erythromycin |
Tablet | | | Refer to USP | | | 12/24/2015 |
| Trametinib Dimethyl Sulfoxide |
Tablet | II (Paddle) | 60 | pH 4.5, 50 mM Sodium Acetate with 0.75% Sodium Lauryl Sulfate [SLS] | 500 | 5, 10, 15, 20 and 30 | 12/24/2015 |
| Empagliflozin/Linagliptin |
Tablet | II (Paddle) | 50 | pH 6.8 Phosphate Buffer | 900 | 10, 15, 20, 30 and 45 | 12/24/2015 |
| Carbamazepine |
Tablet | | | Refer to USP | | | 12/24/2015 |
| Medroxyprogesterone Acetate |
Tablet | | | Refer to USP | | | 12/24/2015 |
| Atazanavir Sulfate/ Cobicistat |
Tablet | II (Paddle) | 75 | 0.05 M Citrate Buffer (pH 2.8) | 1000 | Atazanavir: 10, 15, 20, 30 and 45; Cobicistat: 5, 10, 15, 20 and 30 | 12/24/2015 |
| Linaclotide |
Capsule | I (Basket) | 50 | 50 mM Phosphate Buffer, pH 4.5 | 500 | 5, 10, 15, 20 and 30 | 12/24/2015 |
| Oxybutynin Chloride |
Tablet (Extended Release) | | | Refer to USP | | | 12/24/2015 |
| Carvedilol |
Tablet | | | Refer to USP | | | 12/24/2015 |
| Potassium Chloride |
Capsule (Extended Release) | | | Refer to USP | | | 12/24/2015 |
| Mercaptopurine |
Oral Suspension | II (Paddle) | 50 | 0.1N HCl | 900 | 5, 10, 15, 20 and 30 | 12/24/2015 |
| Prednisone |
Tablet | | | Refer to USP | | | 12/24/2015 |
| Ethinyl Estradiol/Norethindrone Acetate [0.01mg,0.01 mg;1 mg] |
Tablet (Chewable) | II (Paddle) | 75 | 0.025 M Na Acetate Buffer with 0.15% Sodium Lauryl Sulfate [SLS] (pH 5.0) [degassed] | 500 | 10, 15, 20, 30 and 45 | 12/24/2015 |
| Olanzapine Pamoate |
For Intramuscular Suspension (Extended Release) | IV (Flow through cell), 22.6 mm cell | Flow @ 3 mL/min | 1% SLS in pH 6.8 Phosphate Buffer | use Open Mode | 10, 20, 30, 45, 60, 75, 90, 105, 120, 150, 180, 240, 360, 480, 600, and 720 | 12/24/2015 |
| Vorapaxar Sulfate |
Tablet | II (Paddle) | 50 | 41 mM Na2HPO4, 1.5% Citric Acid, pH 3.0 ± 0.5 | 900 | 5, 10, 20, 30, 45 and 60 | 12/24/2015 |
| Elvitegravir |
Tablet | II (Paddle) with sinker | 75 | 2.0% w/v Polysorbate 80 in 0.01 N HCl (pH 2.0) at 37 ºC | 700 mL for 85 mg tablets; 1000 mL for 150 mg tablets 1000 mL for 150 mg tablets | 10, 20, 30, 45 and 60 | 12/24/2015 |
| Benzonatate |
Capsule | | | Refer to USP | | | 12/24/2015 |
| Estrogens, Conjugated (EC)/Medroxyprogesterone Acetate (MPA) |
Tablet | II (Paddle) with sinker | 50 | EC: 0.02 M Na Acetate Buffer (pH 4.5); MPA: 0.54% Sodium Lauryl Sulfate [SLS] in water | 900 | | 12/24/2015 |
| Riociguat |
Tablet | II (Paddle) | 75 | pH 6.8 Phosphate Buffer with 0.1% Sodium Lauryl Sulfate [SLS] | 900 | 5, 10, 15, 20 and 30 | 12/24/2015 |
| Lomustine |
Capsule | | | Develop a dissolution method | | | 12/24/2015 |
